In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D).

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Researchers determined second malignant neoplasms and cardiovascular disease present a persistent and meaningful risk for mortality among survivors of HL.

Moderate to severe OSA was associated with increased risk for severe and critical COVID-19, particularly in those with severe intermittent hypoxia.

Moderate-to-vigorous physical activity (MVPA) decreases from young adulthood into middle age, with accelerated declines seen within 2 years prior to a cardiovascular disease (CVD) event.

There are similar outcomes between patients transported by EMS and mobile stroke units, but mobile stroke units have more favorable time metrics.

Cardiovascular disease risk prediction is not improved by incorporating measures of anxiety and depression in the AHA’s PREVENT predictors.

Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.

In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome, especially heart failure events.

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body shapes and sizes.

There are similar 6-year outcomes between balloon-expandable and self-expanding transcatheter aortic valve implantations.

All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline.